Literature DB >> 1434530

Carbohydrate metabolism in human renal clear cell carcinomas.

P Steinberg1, S Störkel, F Oesch, W Thoenes.   

Abstract

BACKGROUND: Renal cell carcinomas can be subclassified into clear cell carcinomas, chromophobe cell carcinomas, chromophilic cell carcinomas, and oncocytomas. Previous studies, in which no distinction among the different types of renal cell tumors and their grades of malignancy was performed, showed that these tumors had high glycolytic rates. EXPERIMENTAL
DESIGN: The carbohydrate metabolism of control human kidney samples and renal clear cell carcinomas with different degrees of cytologic malignancy (G I, G II, and G III) was studied by determining the glycogen and glucose-6-phosphate levels and the activities of key enzymes involved in glycolysis (hexokinase, glucokinase, pyruvate kinase), gluconeogenesis (glucose-6-phosphatase, fructose-1,6-diphosphatase), and the pentose phosphate pathway (glucose-6-phosphate dehydrogenase) in these tissues and compared with those of a limited number of chromophilic cell carcinomas, chromophobe cell carcinomas, and oncocytomas.
RESULTS: The glycogen and glucose-6-phosphate levels were significantly higher in G I, G II, and G III clear cut carcinomas than in control kidneys; glucokinase, hexokinase, and glucose-6-phosphate dehydrogenase activities remained unchanged, pyruvate kinase activity was enhanced, and glucose-6-phosphatase as well as fructose-1,6-diphosphatase activities were strongly reduced when compared with control kidney values. In chromophilic cell carcinomas glycogen content, glucose-6-phosphate dehydrogenase, and pyruvate kinase activities were elevated, while fructose-1,6-diphosphatase activity was reduced. In chromophobe cell carcinomas glycogen content was elevated and gluconeogenesis was reduced, whereas glycolysis was not activated. In oncocytomas glycogen was not detected and glucose-6-phosphate dehydrogenase, pyruvate kinase, and fructose-1,6-diphosphatase activities remained unchanged.
CONCLUSIONS: It has been demonstrated that a series of characteristic changes occur in the carbohydrate metabolism of renal clear cell carcinomas: glycogen and glucose-6-phosphate levels increase, glycolysis is activated, and gluconeogenesis is reduced. Furthermore, the alterations of the carbohydrate metabolism within clear cell carcinomas are clearly distinct from those observed in chromophilic cell carcinomas, chromophobe cell carcinomas, and oncocytomas.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1434530

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  15 in total

1.  Analysis and interpretation of transcriptomic data obtained from extended Warburg effect genes in patients with clear cell renal cell carcinoma.

Authors:  Edward Sanders; Svenja Diehl
Journal:  Oncoscience       Date:  2015-02-17

2.  Elevated content of p53 protein in the absence of p53 gene mutations as a possible prognostic marker for human renal cell tumors.

Authors:  G Chemeris; A Loktinov; A Rempel; M Schwarz; P Bannasch
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array.

Authors:  J M Boer; W K Huber; H Sültmann; F Wilmer; A von Heydebreck; S Haas; B Korn; B Gunawan; A Vente; L Füzesi; M Vingron; A Poustka
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

4.  Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma.

Authors:  Sébastien Le Jan; Céline Amy; Aurélie Cazes; Catherine Monnot; Noël Lamandé; Judith Favier; Josette Philippe; Mathilde Sibony; Jean-Marie Gasc; Pierre Corvol; Stéphane Germain
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 5.  The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy.

Authors:  S Mazurek; C B Boschek; E Eigenbrodt
Journal:  J Bioenerg Biomembr       Date:  1997-08       Impact factor: 2.945

6.  Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma.

Authors:  J Roigas; S Deger; J Schroeder; A Wille; I Turk; B Brux; K Jung; D Schnorr; S A Loening
Journal:  Urol Res       Date:  2003-09-26

7.  L- and M2-pyruvate kinase expression in renal cell carcinomas and their metastases.

Authors:  U Brinck; E Eigenbrodt; M Oehmke; S Mazurek; G Fischer
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

8.  Renal carcinogenesis in models of diabetes in rats: metabolic changes are closely related to neoplastic development.

Authors:  F Dombrowski; L Klotz; P Bannasch; M Evert
Journal:  Diabetologia       Date:  2007-10-19       Impact factor: 10.122

9.  Morphological classification of renal cancer.

Authors:  S Störkel; E van den Berg
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

10.  Over-expression of glucose transporter isoform GLUT1 and hexokinase I in rat renal oncocytic tubules and oncocytomas.

Authors:  Y S Ahn; A Rempel; H Zerban; P Bannasch
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.